NO20062710L - 1-N-fenyl-amino-1H-imidazolderivater og farmasoytiske sammensetninger - Google Patents

1-N-fenyl-amino-1H-imidazolderivater og farmasoytiske sammensetninger

Info

Publication number
NO20062710L
NO20062710L NO20062710A NO20062710A NO20062710L NO 20062710 L NO20062710 L NO 20062710L NO 20062710 A NO20062710 A NO 20062710A NO 20062710 A NO20062710 A NO 20062710A NO 20062710 L NO20062710 L NO 20062710L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
phenylamino
imidazole derivatives
relates
hormone
Prior art date
Application number
NO20062710A
Other languages
English (en)
Norwegian (no)
Inventor
Paule Bonnet
Jean Lafay
Benoit Rondot
Jacqueline Shields
Igor Duc
Eric Duranti
Thierry Clerc
Francois Puccio
Christian Blot
Philippe Maillos
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34702365&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20062710(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP03293152A external-priority patent/EP1544195A1/en
Application filed by Theramex filed Critical Theramex
Publication of NO20062710L publication Critical patent/NO20062710L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D419/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20062710A 2003-12-15 2006-06-12 1-N-fenyl-amino-1H-imidazolderivater og farmasoytiske sammensetninger NO20062710L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03293152A EP1544195A1 (en) 2003-12-15 2003-12-15 1-N-phenyl-amino- 1H-imidazole derivatives and pharmaceutical compositions containing them
EP04292681 2004-11-12
PCT/EP2004/014847 WO2005058842A1 (en) 2003-12-15 2004-12-15 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
NO20062710L true NO20062710L (no) 2006-06-30

Family

ID=34702365

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062710A NO20062710L (no) 2003-12-15 2006-06-12 1-N-fenyl-amino-1H-imidazolderivater og farmasoytiske sammensetninger

Country Status (18)

Country Link
US (1) US8476455B2 (ru)
EP (1) EP1694650A1 (ru)
JP (2) JP4834557B2 (ru)
KR (1) KR20060123186A (ru)
CN (1) CN1890221B (ru)
AR (1) AR047144A1 (ru)
AU (1) AU2004299286B2 (ru)
BR (1) BRPI0417407A (ru)
CA (1) CA2549603A1 (ru)
IL (1) IL176077A0 (ru)
MA (1) MA28286A1 (ru)
MX (1) MXPA06006837A (ru)
NO (1) NO20062710L (ru)
NZ (1) NZ548399A (ru)
OA (1) OA13336A (ru)
RU (1) RU2365586C2 (ru)
TW (1) TW200533668A (ru)
WO (1) WO2005058842A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127923D0 (en) 2001-11-21 2002-01-16 Sterix Ltd Compound
WO2008003378A1 (de) * 2006-07-05 2008-01-10 Merck Patent Gmbh Sulfamat-benzothiophen-derivate
JP2010511640A (ja) * 2006-12-04 2010-04-15 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング スルファマトベンゾチオフェン(sulfamatobenzothiophene)誘導体
EP2207544A2 (en) 2007-09-17 2010-07-21 PregLem S.A. Treatment of oestrogen dependant conditions in pre-menopausal women
GB0914767D0 (en) * 2009-08-24 2009-09-30 Sterix Ltd Compound
AU2016366680B2 (en) 2015-12-09 2021-06-24 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective estrogen receptor downregulators
IL267795B2 (en) 2017-01-06 2023-02-01 G1 Therapeutics Inc Combined treatment for cancer
WO2018187414A1 (en) * 2017-04-05 2018-10-11 The Regents Of The University Of California Inhibitors of mtor-rictor interactions
WO2019241156A1 (en) * 2018-06-11 2019-12-19 Loma Linda University Methods of delaying and reversing alzheimer's disease progression

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558625A (en) * 1968-10-31 1971-01-26 Merck & Co Inc Pyrazinecarboxyaldehydes and method for their preparation
BE757186A (fr) 1969-10-07 1971-04-07 Bayer Ag Nouveaux esters d'acides pyridazino-thiono-phosphoriques et-phosphoniques, leur procede de preparation et leur application comme insecticides et acaricides
US4166452A (en) * 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4584302A (en) 1983-09-26 1986-04-22 Mcneilab, Inc. Methods for the treatment of ventricular dysrhythmia and prevention of ventricular fibrillation
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US5071861A (en) * 1986-03-07 1991-12-10 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
DE3811574A1 (de) * 1988-03-31 1989-10-19 Schering Ag N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JP2500849B2 (ja) * 1991-09-02 1996-05-29 山之内製薬株式会社 トリアゾリル置換3級アミノ化合物又はその塩
WO1993005027A1 (en) 1991-09-02 1993-03-18 Yamanouchi Pharmaceutical Co., Ltd. Triazolylated tertiary amine compound or salt thereof
GB2273704B (en) * 1992-12-16 1997-01-22 Orion Yhtymae Oy Triazolyl diaryl selective aromatase inhibiting compounds
WO1996035688A1 (fr) 1995-05-08 1996-11-14 Nippon Chemiphar Co., Ltd. Derives de 2,4-thiazolidinedione ou d'oxazolidinedione et agent hypoglycemique
GB9807779D0 (en) 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
JP4320089B2 (ja) * 1999-07-06 2009-08-26 あすか製薬株式会社 フェニルスルファメート誘導体
US6436972B1 (en) 2000-04-10 2002-08-20 Dalhousie University Pyridones and their use as modulators of serine hydrolase enzymes
JP2004524289A (ja) 2000-12-22 2004-08-12 アストラゼネカ・アクチエボラーグ 治療化合物
MXPA03007546A (es) 2001-02-23 2004-10-15 Leuven K U Res & Dev Derivados de n-aminoimidazol inhibidores del vih.
CN1370533A (zh) 2001-02-27 2002-09-25 中国人民解放军军事医学科学院放射医学研究所 一类新的苯并噻吩类化合物在防治妇女绝经后综合症和其它与雌激素相关疾病中的用途
US7109193B2 (en) * 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
AU2002339192A1 (en) * 2001-11-21 2003-06-10 Sterix Limited 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
GB0127923D0 (en) * 2001-11-21 2002-01-16 Sterix Ltd Compound
US7440571B2 (en) * 2002-12-03 2008-10-21 Nagravision S.A. Method for securing software updates
JP2004196795A (ja) * 2002-12-16 2004-07-15 Wyeth 外部寄生虫駆除剤としてのn−フェニル−3−シクロプロピルピラゾール−4−カルボニトリル
US6737433B1 (en) * 2002-12-16 2004-05-18 Laboratoire Theramex 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors and pharmaceutical compositions containing them
NZ544013A (en) 2003-05-16 2009-04-30 Theramex Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors

Also Published As

Publication number Publication date
CA2549603A1 (en) 2005-06-30
RU2006125417A (ru) 2008-01-27
IL176077A0 (en) 2006-10-05
US8476455B2 (en) 2013-07-02
NZ548399A (en) 2011-01-28
JP2007515420A (ja) 2007-06-14
BRPI0417407A (pt) 2007-04-03
US20070112009A1 (en) 2007-05-17
JP4834557B2 (ja) 2011-12-14
CN1890221B (zh) 2014-07-16
MA28286A1 (fr) 2006-11-01
OA13336A (en) 2006-04-13
RU2365586C2 (ru) 2009-08-27
MXPA06006837A (es) 2006-09-04
JP2011190277A (ja) 2011-09-29
AR047144A1 (es) 2006-01-11
AU2004299286B2 (en) 2011-06-30
WO2005058842A1 (en) 2005-06-30
CN1890221A (zh) 2007-01-03
JP5209760B2 (ja) 2013-06-12
TW200533668A (en) 2005-10-16
KR20060123186A (ko) 2006-12-01
EP1694650A1 (en) 2006-08-30
AU2004299286A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
NO20062710L (no) 1-N-fenyl-amino-1H-imidazolderivater og farmasoytiske sammensetninger
IL173810A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
NO20050828L (no) lndol-3-svovelderivater
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
SE0302811D0 (sv) Novel compounds
SE0301700D0 (sv) Novel compounds
ATE433447T1 (de) Pyrimiidinverbindungen
MXPA03008754A (es) Derivados de piridina fundidos para utilizarse como agonistas receptores vaniloide para tratar dolor.
NO20054787D0 (no) Indenderivater som farmasotiske midler
RS20060129A (en) /1,8/naphthyridin-2-ones and related compounds for the treatment of schizophrenia
IS6658A (is) Ný efnasambönd
SE0104140D0 (sv) Novel Compounds
NO20063062L (no) Imidazolderivater, fremgangsmate for fremstilling og anvendelse av disse
SE0302139D0 (sv) Novel compounds
WO2004106293A3 (en) Oxazolyl - and thiazolyl - purine based tricyclic compounds.
NO20062629L (no) Oksazolderivater av tetrackliner
TW200740781A (en) Novel compounds
SE0303541D0 (sv) New compounds
IL173895A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
IL173809A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
IL159554A0 (en) Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
NO20055749L (no) Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer
IL151198A0 (en) Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
IL173629A0 (en) Imidazo(4,5-b) pyridine derivatives and pharmaceutical compositions containing the same
WO2005011609A3 (en) Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application